Age-related macular degeneration (AMD) is a multifactorial disease influenced by a
combination of environmental factors and genetic variants. Genomic studies have been …

Visual acuity is a key outcome measure in the treatment of neovascular age-related macular
degeneration (nAMD) using anti-vascular endothelial growth factor agents. Large variations …

Polypoidal choroidal vasculopathy (PCV) is usually regarded as a subtype of choroidal
neovascularization (CNV) that is secondary to age-related macular degeneration (AMD) …

Precision medicine aims to improve patient care by adjusting medication to each patient's
individual needs. Age-related macular degeneration (AMD) is a heterogeneous eye disease …

Age-related macular degeneration (AMD) is a complex disease with multiple genetic and
environmental risk factors. In the age of molecular genetics, many investigators have …

Background and Objectives: The age-related macular degeneration (AMD) pathophysiology
is multifactorial, as it consists of interactions between aging, genetic, and environmental …

Objectives To investigate the role of polymorphism rs11200638 of high-temperature
requirement factor A-1 (HtrA1) gene in the pathogenesis of age-related macular …

Purpose: To identify the association between single-nucleotide polymorphisms (SNPs) in
CFH, ARMS2, HTRA1, CFB, C2, and C3 genes and exudative age-related macular …

Age-related macular degeneration (AMD) causes irreversible vision loss, and targeted anti-
vascular endothelial growth factor (VEGF) therapy is now the most common and effective …

Introduction The aim of this study was to investigate the association of the HtrA1 rs11200638
polymorphism with neovascular age-related macular degeneration (nAMD) in Indonesia …